Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
Americas
Clear all
Type of publications
NITAG documentation
(105)
Scientific publications
(3)
Systematic reviews (SYSVAC)
(8)
Topics
Regions
Americas
(116)
Countries
Canada
(116)
Argentina
(30)
Bolivia
(3)
Brazil
(4)
Chile
(66)
Colombia
(1)
Costa Rica
(1)
Honduras
(14)
Mexico
(1)
Nicaragua
(1)
Peru
(2)
United States of America
(430)
Uruguay
(2)
Diseases
COVID-19
(41)
Diphtheria
(2)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(20)
Measles
(1)
Meningococcal disease
(7)
Mpox // Monkeypox
(2)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(7)
Rabies
(1)
Rotavirus
(2)
Rubella
(1)
Tuberculosis
(1)
Varicella
(4)
Publication date
2024
(1)
2023
(11)
2022
(21)
2021
(19)
2020
(10)
2019
(4)
2018
(5)
2017
(4)
2016
(3)
2015
(6)
2014
(8)
2013
(1)
2010
(11)
2009
(4)
2008
(5)
2006
(1)
2005
(1)
Target population
Adolescents
(2)
Adults
(5)
All age groups
(6)
Children
(1)
Healthcare workers
(3)
Newborn
(1)
Older adults
(5)
Parents/caregivers
(1)
Pregnant women
(2)
Available to download in languages
English (EN)
(91)
French (FR)
(38)
116 results found
2018
∙
NACI
Update on immunization in pregnancy with tetanus toxoid, reduced diphtheria toxoid and reduced acellular pertussis (Tdap) vaccine
2017
∙
NACI
NACI Literature Review for HPV Immunization of Immunocompromised Populations
2017
∙
NACI
National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2017–2018
2017
∙
NACI
Update on the recommended use of Hepatitis B vaccine
2017
∙
NACI
Updated Recommendations on Human Papillomavirus (HPV) Vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations
2016
∙
Chit, A. Lee, J. K. Shim, M. Nguyen, V. H. Grootendorst, P. Wu, J. Van Exan, R. Langley, J. M.
Economic evaluation of vaccines in Canada: A systematic review
2016
∙
NACI
ADDENDUM - LAIV Use in Children and Adolescents
2016
∙
NACI
ADDENDUM - LAIV Use in Egg Allergic Individuals Advisory Committee Statement (ACS)
2015
∙
NACI
Literature Review on Pediatric Fluad® Influenza Vaccine Use in Children 6-72 Months of Age
2015
∙
NACI
NACI Opinion on LAIV Effectiveness in Young Children
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register